• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MPC聚合物通过稳定眼表促进干眼症的恢复。

MPC Polymer Promotes Recovery from Dry Eye via Stabilization of the Ocular Surface.

作者信息

Nagai Noriaki, Sakurai Shunsuke, Seiriki Ryotaro, Minami Misa, Yamaguchi Mizuki, Deguchi Saori, Harata Eiji

机构信息

Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka 577-8502, Japan.

Life Science Products Division, NOF Corporation, Yebisu Garden Place Tower, 20-3 Ebisu 4-chome, Shibuya-ku, Tokyo 150-6019, Japan.

出版信息

Pharmaceutics. 2021 Jan 27;13(2):168. doi: 10.3390/pharmaceutics13020168.

DOI:10.3390/pharmaceutics13020168
PMID:33513827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7910948/
Abstract

The polymer that includes 2-methacryloyloxy ethyl phosphorylcholine (MPC) is well-known as an effectively hydrating multifunction agent. In this study, we prepared an MPC polymer (MPCP) using radical polymerization with co-monomers-MPC/Stearyl Methacrylate/,-dimethylacrylamide-and evaluated the MPCP's usefulness for dry eye treatment using a rabbit model treated with -acetylcysteine. The MPCP particle size was 50-250 nm, and the form was similar to that of micelles. The MPCP viscosity (approximately 0.95 mPa·s) was 1.17-fold that of purified water, and a decrease in the transepithelial electrical resistance value (corneal damage) was not observed in the immortalized human corneal epithelial cell line HCE-T cell (HCE-T cell layer). The MPCP enhanced the water maintenance on the cornea, and the instillation of MPCP increased the lacrimal fluid volume and prolonged the tear film breakup time without an increase in total mucin contents in the lacrimal fluid of the normal rabbits. The therapeutic potential of the MPCP for dry eye was evaluated using an -acetylcysteine-treated rabbit model, and, in our investigation, we found that MPCP enhanced the volume of lacrimal fluid and promoted an improvement in the tear film breakup levels. These findings regarding the creation and characteristics of a novel MPCP will provide relevant information for designing further studies to develop a treatment for dry eyes.

摘要

包含2-甲基丙烯酰氧乙基磷酰胆碱(MPC)的聚合物是一种众所周知的高效保湿多功能剂。在本研究中,我们使用自由基聚合法,以MPC/甲基丙烯酸硬脂酯/ N,N-二甲基丙烯酰胺作为共聚单体,制备了一种MPC聚合物(MPCP),并使用经N-乙酰半胱氨酸处理的兔模型评估了MPCP在干眼症治疗中的效用。MPCP的粒径为50-250nm,形态与胶束相似。MPCP的粘度(约0.95mPa·s)是纯净水的1.17倍,在永生化人角膜上皮细胞系HCE-T细胞(HCE-T细胞层)中未观察到跨上皮电阻值降低(角膜损伤)。MPCP增强了角膜上的水分保持能力,滴注MPCP可增加正常兔泪液体积并延长泪膜破裂时间,而泪液中总粘蛋白含量并未增加。我们使用经N-乙酰半胱氨酸处理的兔模型评估了MPCP对干眼症的治疗潜力,在我们的研究中,发现MPCP增加了泪液体积并促进了泪膜破裂水平的改善。这些关于新型MPCP的制备和特性的发现将为设计进一步的研究以开发干眼症治疗方法提供相关信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/278bde055753/pharmaceutics-13-00168-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/c409fcf6ba4a/pharmaceutics-13-00168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/bcdc1447229a/pharmaceutics-13-00168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/689f59a5486b/pharmaceutics-13-00168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/3d3020574d56/pharmaceutics-13-00168-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/e8ab42bc467b/pharmaceutics-13-00168-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/386157f07d1c/pharmaceutics-13-00168-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/278bde055753/pharmaceutics-13-00168-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/c409fcf6ba4a/pharmaceutics-13-00168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/bcdc1447229a/pharmaceutics-13-00168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/689f59a5486b/pharmaceutics-13-00168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/3d3020574d56/pharmaceutics-13-00168-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/e8ab42bc467b/pharmaceutics-13-00168-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/386157f07d1c/pharmaceutics-13-00168-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a78/7910948/278bde055753/pharmaceutics-13-00168-g007.jpg

相似文献

1
MPC Polymer Promotes Recovery from Dry Eye via Stabilization of the Ocular Surface.MPC聚合物通过稳定眼表促进干眼症的恢复。
Pharmaceutics. 2021 Jan 27;13(2):168. doi: 10.3390/pharmaceutics13020168.
2
Copolymerized Polymers Based on Cyclodextrins and Cationic Groups Enhance Therapeutic Effect of Rebamipide in the N-Acetylcysteine-Treated Dry Eye Model.基于环糊精和阳离子基团的共聚聚合物增强了 N-乙酰半胱氨酸处理的干眼模型中瑞巴派特的治疗效果。
Drug Des Devel Ther. 2024 Sep 27;18:4345-4358. doi: 10.2147/DDDT.S469445. eCollection 2024.
3
Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.在泪腺炎症诱导的干眼兔模型中,地塞米松对泪膜完整性的保护及角膜损伤的抑制作用
J Ocul Pharmacol Ther. 2005 Apr;21(2):139-48. doi: 10.1089/jop.2005.21.139.
4
Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells.新型人工泪液中含有 2-甲基丙烯酰氧乙基磷酰胆碱聚合物对眼表细胞的细胞毒性研究。
Jpn J Ophthalmol. 2011 Sep;55(5):541-546. doi: 10.1007/s10384-011-0073-8. Epub 2011 Aug 10.
5
Mucoadhesive, antioxidant, and lubricant catechol-functionalized poly(phosphobetaine) as biomaterial nanotherapeutics for treating ocular dryness.具有黏附性、抗氧化和润滑作用的儿茶酚功能化聚(磷甜菜碱)作为治疗眼部干燥的生物材料纳米疗法。
J Nanobiotechnology. 2024 Apr 8;22(1):160. doi: 10.1186/s12951-024-02448-x.
6
Prolactin Inducible Protein, but Not Prolactin, Is Present in Human Tears, Is Involved in Tear Film Quality, and Influences Evaporative Dry Eye Disease.催乳素诱导蛋白而非催乳素存在于人类泪液中,参与泪膜质量的维持,并影响蒸发过强型干眼疾病。
Front Med (Lausanne). 2022 Jun 30;9:892831. doi: 10.3389/fmed.2022.892831. eCollection 2022.
7
Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide Nanoparticles.用于干眼症治疗的瑞巴派特纳米颗粒新型缓释给药系统
Pharmaceutics. 2020 Feb 14;12(2):155. doi: 10.3390/pharmaceutics12020155.
8
Poly 2-methacryloyloxyethyl Phosphorylcholine Protects Corneal Cells and Contact Lenses from Desiccation Damage.聚(2-甲基丙烯酰氧乙基)磷酰胆碱可保护角膜细胞和隐形眼镜免受干燥损伤。
Optom Vis Sci. 2021 Feb 1;98(2):159-169. doi: 10.1097/OPX.0000000000001642.
9
Therapeutic efficacy of fibroblast growth factor 10 in a rabbit model of dry eye.成纤维细胞生长因子10在兔干眼模型中的治疗效果
Mol Med Rep. 2015 Nov;12(5):7344-50. doi: 10.3892/mmr.2015.4368. Epub 2015 Sep 25.
10
A Comprehensive Assessment of Tear-Film-Oriented Diagnosis (TFOD) in a Dacryoadenectomy Dry Eye Model.泪膜导向诊断(TFOD)在干燥性眼模型中的全面评估。
Int J Mol Sci. 2023 Nov 20;24(22):16510. doi: 10.3390/ijms242216510.

引用本文的文献

1
Resin Composites with Anti-Biofouling Zwitterionic Polymer and Silica/Zirconia Filler for Digital Light Processing (DLP) of Dental Protheses.用于牙科修复体数字光处理(DLP)的含抗生物污损两性离子聚合物和二氧化硅/氧化锆填料的树脂复合材料。
Materials (Basel). 2025 Aug 5;18(15):3677. doi: 10.3390/ma18153677.
2
A Personal Scientific Journey in Ophthalmology: Twenty-Five Years of Translating Research into Novel Therapies.眼科领域的个人科学之旅:将研究转化为新型疗法的二十五年
Pharmaceuticals (Basel). 2025 Jun 12;18(6):883. doi: 10.3390/ph18060883.
3
Copolymerized Polymers Based on Cyclodextrins and Cationic Groups Enhance Therapeutic Effect of Rebamipide in the N-Acetylcysteine-Treated Dry Eye Model.

本文引用的文献

1
In Situ Gelling Systems Using Pluronic F127 Enhance Corneal Permeability of Indomethacin Nanocrystals.利用泊洛沙姆 F127 的原位凝胶系统增强吲哚美辛纳米晶体的角膜透过性。
Int J Mol Sci. 2020 Sep 25;21(19):7083. doi: 10.3390/ijms21197083.
2
Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide Nanoparticles.用于干眼症治疗的瑞巴派特纳米颗粒新型缓释给药系统
Pharmaceutics. 2020 Feb 14;12(2):155. doi: 10.3390/pharmaceutics12020155.
3
Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles.
基于环糊精和阳离子基团的共聚聚合物增强了 N-乙酰半胱氨酸处理的干眼模型中瑞巴派特的治疗效果。
Drug Des Devel Ther. 2024 Sep 27;18:4345-4358. doi: 10.2147/DDDT.S469445. eCollection 2024.
4
Mucoadhesive, antioxidant, and lubricant catechol-functionalized poly(phosphobetaine) as biomaterial nanotherapeutics for treating ocular dryness.具有黏附性、抗氧化和润滑作用的儿茶酚功能化聚(磷甜菜碱)作为治疗眼部干燥的生物材料纳米疗法。
J Nanobiotechnology. 2024 Apr 8;22(1):160. doi: 10.1186/s12951-024-02448-x.
5
Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease.垂体腺苷酸环化酶激活肽治疗干眼症的潜在作用。
Int J Mol Sci. 2022 Jan 8;23(2):664. doi: 10.3390/ijms23020664.
6
Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges.用于眼科疾病的先进治疗药物:目标与挑战。
Pharmaceutics. 2021 Nov 1;13(11):1819. doi: 10.3390/pharmaceutics13111819.
能量依赖性内吞作用是导致含吲哚美辛纳米粒的眼用制剂滴眼后药物经角膜穿透的原因。
Int J Nanomedicine. 2019 Feb 18;14:1213-1227. doi: 10.2147/IJN.S196681. eCollection 2019.
4
Instillation of Sericin Enhances Corneal Wound Healing through the ERK Pathway in Rat Debrided Corneal Epithelium.丝胶灌注通过 ERK 通路增强大鼠角膜上皮清创后角膜伤口愈合。
Int J Mol Sci. 2018 Apr 9;19(4):1123. doi: 10.3390/ijms19041123.
5
TFOS DEWS II Epidemiology Report.TFOS DEWS II 流行病学报告。
Ocul Surf. 2017 Jul;15(3):334-365. doi: 10.1016/j.jtos.2017.05.003. Epub 2017 Jul 20.
6
TFOS DEWS II Definition and Classification Report.TFOS DEWS II 定义与分类报告。
Ocul Surf. 2017 Jul;15(3):276-283. doi: 10.1016/j.jtos.2017.05.008. Epub 2017 Jul 20.
7
Investigational drugs in dry eye disease.干眼症的研究性药物。
Expert Opin Investig Drugs. 2016 Dec;25(12):1437-1446. doi: 10.1080/13543784.2016.1249564. Epub 2016 Oct 28.
8
Treatment of Dry Eye Disease.干眼症的治疗
Consult Pharm. 2016 Feb;31(2):96-106. doi: 10.4140/TCP.n.2016.96.
9
Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells.新型人工泪液中含有 2-甲基丙烯酰氧乙基磷酰胆碱聚合物对眼表细胞的细胞毒性研究。
Jpn J Ophthalmol. 2011 Sep;55(5):541-546. doi: 10.1007/s10384-011-0073-8. Epub 2011 Aug 10.
10
Bioinspired interface for nanobiodevices based on phospholipid polymer chemistry.基于磷脂聚合物化学的纳米生物器件的仿生界面
J R Soc Interface. 2009 Jun 6;6 Suppl 3(Suppl 3):S279-91. doi: 10.1098/rsif.2008.0335. Epub 2009 Mar 4.